Successful treatment of generalized essential telangiectasia with 6-mercaptopurine

Alex M. Glazer, Bryan D. Sofen, Darrell S. Rigel, Jerome L. Shupack

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Generalized essential telangiectasia (GET) is a notoriously difficult to treat disorder with no current satisfactory treatments. This case and discussion report the use of 6-mercaptopurine (6-MP) as a successful treatment for GET. Moreover, we show that GET may represent a state of increased angiogenesis, a paradigm shift from the current understanding that these telangiectasias represent dilatations of only preexisting vessels. This new view of GET may drive others to look at novel agents for treatment.

Original languageEnglish
Pages (from-to)280-282
Number of pages3
JournalJournal of Drugs in Dermatology
Issue number3
StatePublished - Mar 2017
Externally publishedYes


Dive into the research topics of 'Successful treatment of generalized essential telangiectasia with 6-mercaptopurine'. Together they form a unique fingerprint.

Cite this